Overview
Dr Scott-Ames is a Transplant Surgeon practicing medicine in New York, New York.
Dr. Scott-Ames is highly rated in 4 conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Chronic Antibody-Mediated Rejection, Simultaneous Pancreas Kidney Transplant, and Kidney Transplant.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
5 E 98th St Fl 12, New York, NY 10029
CUIMC/Milstein Hospital Building
Joshua Sonett is a Thoracic Surgeon and a Transplant Surgeon practicing medicine in New York, New York. Dr. Sonett is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), Lung Transplant, and Thymectomy. Dr. Sonett is board certified in Thoracic And Cardiac Surgery. Dr. Sonett is currently accepting new patients.
CUIMC/Presbyterian Hospital And Vanderbilt Clinic
Dr. Gene Im is a transplant hepatologist and the Director of the Alcohol-associated Liver Disease Program at Columbia known as ADAPT (Advanced inter-Disciplinary Alcohol liver Program and Treatment), a patient-centered, integrated care and research program for patients with alcohol-associated liver disease (ALD). ADAPT is one of only a few integrated ALD clinics in the country.Dr. Im is an internationally recognized expert in ALD, including alcohol-associated hepatitis and liver transplantation based on his clinical focus and research achievements. He has co-authored several practice-changing articles, including the 2019 ALD Practice Guidance from AASLD, the 2024 MetALD Expert Position Statement, and the first experience of early liver transplantation for alcohol-associated hepatitis in North America.Currently, he is the Vice-Chair of the AASLD ALD Special Interest Group and serves on the Editorial Board for the journal Liver Transplantation. Dr. Im is also the founder of ALD-ALLY (Alcohol-associated Liver Disease patients deserve ALcohol LiteracY), an annual conference focused on actionable initiatives for advancing the science and care of patients with alcohol use disorder and ALD (www.ald-ally.com)Dr. Im is an Assistant Professor of Medicine in the Center for Liver Disease and Transplantation and Division of Digestive and Liver Diseases at Columbia University. Dr. Im is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Hepatitis, Alcoholic Cirrhosis, Liver Failure, Liver Transplant, and Hepato-Pancreato-Biliary Surgery. Dr. Im is board certified in Gastroenterology and Transplant Hepatology. Dr. Im is currently accepting new patients.
CUIMC/Herbert Irving Pavilion
Dr. Mapara is Professor of Medicine at Columbia University Medical Center and the Director of the Blood and Marrow Transplantation (BMT)/Cell Therapy Program at New York Presbyterian Hospital/Columbia University Medical Center. Dr. Mapara graduated from the University of Heidelberg Medical School/Germany, and received his post-graduate training in Internal Medicine and Hematology/Oncology at the Universities of Heidelberg and the University Medical Center Charite of the Humboldt University of Berlin in Germany. In addition, he completed a research fellowship at the Transplantation Biology Research Center of the Massachusetts General Hospital at the Harvard Medical School in Boston. As Assistant Professor of Medicine, he headed the Hematologic Intensive Care Unit and served as deputy director of the Stem Cell Transplantation unit at the University Medical Center Charite in Berlin, Germany. Before coming to Columbia, Dr. Mapara was Associate Professor of Medicine (with tenure) at the University of Pittsburgh Cancer Institute and served as the Director of the Adult Hematopoietic Stem Cell Transplantation Program. Dr. Mapara specializes in the care of patients with sickle cell disease and certain blood cancers (Multiple Myeloma, Amyloidosis) undergoing bone marrow transplantation and gene therapy. His research is focused on developing novel approaches to make bone marrow transplantation and cell therapy safer for patients. Dr. Mapara is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Mapara is board certified in Hematology and Medical Oncology. Dr. Mapara is currently accepting new patients.
CUIMC/Milstein Hospital Building
Dr. Ratner is Professor of Surgery and Director of Renal and Pancreatic Transplantation at Columbia University. Prior to joining the faculty at Columbia, Dr. Ratner was on the faculty of Johns Hopkins University in Baltimore, and served as the Chief of Solid Organ Transplantation at Thomas Jefferson University in Philadelphia. Dr. Ratner was responsible for dramatic growth of the kidney transplant program at CUIMC. He also established the pancreas transplant program, and the Kidney Autotransplant Program. He introduced robotic surgery to our kidney transplant program. Access to organ transplantation has been Dr. Ratner's major academic interest. Dr. Ratner has been a leading innovator in transplantation for over two decades. In 1993, he performed the world's first dual renal transplant. In 1995 (with Dr. Louis Kavoussi) he performed the first laparoscopic donor nephrectomy, and set the stage for its widespread adoption, which resulted in a profound increase in living donor kidney transplantation. Dr. Ratner has made significant contributions in overcoming immunologic incompatibilities that prohibited transplantation. He devised the plasmapheresis/IVIg protocol for alloantibody desensitization in 1998. In 2001, Dr. Ratner orchestrated the second paired-kidney exchange in the U.S. Subsequently, he arranged the first paired kidney exchanges in both Pennsylvania and New York. More recently Dr. Ratner has been a leading proponent of including compatible donor/recipient pairs in kidney exchanges. And, his more contemporary work has looked at the organizational and regulatory barriers to access to care. All of these strategies have increased organ availability and access to transplantation. Additionally, he has made important contributions to improve living donor safety. For his work, Dr. Ratner has received numerous awards and honors. And, he has been invited to speak and operate at various venues around the world. Dr. Ratner has authored or co-authored over 240 peer-reviewed publications, and has been a federally funded investigator. His publications have been cited over 20,000 times. He served as the Chairman of the Board of Directors of the LiveOnNY (formerly the New York Organ Donor Network), and has served on numerous national committees including the Board of the Organ Procurement and Transplantation Network (OPTN). He recently completed a term as the President of the American Society of Transplant Surgeons, and previously served as that Society's Treasurer.Dr. Ratner originally hails from Brooklyn, NY. He received his undergraduate education at the State University of New York at Buffalo. He received his M.D. from Hahnemann University. His general surgery training was obtained at Long Island Jewish Medical Center. He completed a Fellowship in Transplantation Surgery and Immunology at Washington University. In 2011 Dr. Ratner completed a Master of Public Health with a focus on health care policy, administration and management. Dr. Ratner is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Chylous Ascites, Kidney Transplant, and Pancreas Transplant. Dr. Ratner is board certified in Surgery. Dr. Ratner is currently accepting new patients.
CUIMC/NewYork-Presbyterian Morgan Stanley Children's Hospital
Jean Emond is a General Surgeon and a Pediatric Surgeon practicing medicine in New York, New York. Dr. Emond is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Liver Cancer, Liver Failure, Pancreatic Cancer, Liver Transplant, and Hepatectomy. Dr. Emond is board certified in Surgery. Dr. Emond is currently accepting new patients.
Adult Liver Transplant Practice
Jawad Ahmad is a Transplant Surgeon practicing medicine in New York, New York. Dr. Ahmad is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Cholangitis, Sclerosing Cholangitis, Hepatitis, Gallbladder Removal, and Hepato-Pancreato-Biliary Surgery. Dr. Ahmad is currently accepting new patients.
Frequently Asked Questions about Dr. Dr A. Scott-Ames
How do I make an appointment with Dr. Dr A. Scott-Ames?
You can book an appointment with Dr. Dr A. Scott-Ames by calling their office at 212-241-4060. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Dr A. Scott-Ames a top-rated expert for End-Stage Renal Disease (ESRD)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Dr A. Scott-Ames is classified as an Advanced expert for End-Stage Renal Disease (ESRD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Dr A. Scott-Ames specialize in?
While Dr. Dr A. Scott-Ames is a Transplant Surgery, they have specific expertise in End-Stage Renal Disease (ESRD), Simultaneous Pancreas Kidney Transplant, and Kidney Transplant. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Transplant Surgery.
Does Dr. Dr A. Scott-Ames accept my insurance?
Dr. Dr A. Scott-Ames accepts most major insurance plans, including Humana. We recommend calling the office directly at 212-241-4060 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic Antibody-Mediated RejectionDr. Scott-Ames isAdvanced. Learn about Chronic Antibody-Mediated Rejection.
- End-Stage Renal Disease (ESRD)Dr. Scott-Ames isAdvanced. Learn about End-Stage Renal Disease (ESRD).
- Kidney TransplantDr. Scott-Ames isAdvanced. Learn about Kidney Transplant.
- Simultaneous Pancreas Kidney TransplantDr. Scott-Ames isAdvanced. Learn about Simultaneous Pancreas Kidney Transplant.
- Experienced
- NephrectomyDr. Scott-Ames isExperienced. Learn about Nephrectomy.
- Pancreas TransplantDr. Scott-Ames isExperienced. Learn about Pancreas Transplant.
- Reconstructive Urology SurgeryDr. Scott-Ames isExperienced. Learn about Reconstructive Urology Surgery.
- UreteroscopyDr. Scott-Ames isExperienced. Learn about Ureteroscopy.




